A former New Jersey assemblymember said he will push lawmakers to legalize marijuana home cultivation and psilocybin therapy this year. California …
Category: Psychedelics
Relmada halts depression drug trials, shifts focus to psilocybin program amid review
Relmada Therapeutics Inc. (Nasdaq: RLMD) will halt its Phase 3 studies of depression treatment REL-1017 following a data monitoring committee evaluation, sending the company searching for strategic alternatives. The late-stage biotechnology company will discontinue both the Reliance II and Relight Phase 3 studies while continuing development of REL-P11, its modified …
Red Light Holland posts 40% jump in revenue, narrows losses
Canadian psychedelics company Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) cut its quarterly losses and grew sales as its mushroom and truffle business expanded across North America and Europe. Revenue reached C$1.37 million for the quarter ending Sept. 30, up 39.1% from C$983,324 in the year-ago period, according to …